Efficacy and safety of etanercept in moderate to severe plaque psoriasis using two different dosing regimens

被引：0
|
作者：
Mazzotta, A [1 ]
Costanzo, A [1 ]
Giunta, A [1 ]
Chimenti, S [1 ]
机构：
[1] Univ Roma Tor Vergata, Dept Dermatol, Rome, Italy
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2006年 / 54卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB201 / AB201
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of etanercept in moderate to severe plaque psoriasis
    Tunca, M.
    Koc, E.
    Akar, A.
    Kurumlu, Z.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2007, 21 : 53 - 53
  • [2] Adding methotrexate to etanercept versus etanercept monotherapy in adults with moderate to severe plaque psoriasis: Efficacy and safety
    Gottlieb, Alice B.
    Strober, Bruce E.
    Kricorian, Gregory
    Langley, Richard G.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) : AB184 - AB184
  • [3] Safety update of etanercept treatment for moderate to severe plaque psoriasis
    Campanati, Anna
    Diotallevi, Federico
    Martina, Emanuela
    Paolinelli, Matteo
    Radi, Giulia
    Offidani, Annamaria
    [J]. EXPERT OPINION ON DRUG SAFETY, 2020, 19 (04) : 439 - 448
  • [4] Safety and efficacy of adding topical clobetasol propionate to etanercept in patients with moderate to severe plaque psoriasis
    Lebwohl, Mark G.
    Pariser, David
    Kricorian, Gregory
    Koo, John
    Duffin, Kristina Callis
    Kircik, Leon
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB211 - AB211
  • [5] Efficacy and safety of secukinumab in moderate to severe plaque psoriasis
    Aparicio Rubio, Celia
    Monteagudo Santolaya, Emilio
    Cornejo Uixeda, Silvia
    Prieto Castello, Manuel
    Antonino de la Camara, Gonzalo
    Quintana Vergara, Belen
    Sanchez Alcaraz, Agustin
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (01) : 299 - 299
  • [6] Cost-Effectiveness Analysis of Ixekizumab vs Etanercept and Their Manufacturer-Recommended Dosing Regimens in Moderate to Severe Plaque Psoriasis
    Udkoff, Jeremy
    Eichenfield, Lawrence E.
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2017, 16 (10) : 964 - 970
  • [7] Efficacy and safety of briakinumab vs. etanercept and placebo in patients with moderate to severe chronic plaque psoriasis
    Gottlieb, A. B.
    Leonardi, C.
    Kerdel, F.
    Mehlis, S.
    Olds, M.
    Williams, D. A.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (03) : 652 - 660
  • [8] Pharmacokinetics, Immunogenicity, and Efficacy of Etanercept in Pediatric Patients With Moderate to Severe Plaque Psoriasis
    Langley, Richard G.
    Kasichayanula, Sree
    Trivedi, Mona
    Aras, Girish A.
    Kaliyaperumal, Arunan
    Yuraszeck, Theresa
    Gibbs, John
    Gibbs, Megan
    Kricorian, Greg
    Paller, Amy S.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (03): : 340 - 346
  • [9] Efficacy and safety results of briakinumab vs. etanercept and placebo in patients with moderate to severe chronic plaque psoriasis
    Menter, A.
    Gottlieb, A.
    Leonardi, C.
    Kerdel, F.
    Gu, Y.
    Valdes, J.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 : 38 - 39
  • [10] A randomized study to evaluate the efficacy and safety of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis
    Lebwohl, Mark G.
    Kircik, Leon
    Duffin, Kristina Callis
    Pariser, David
    Hooper, Michele
    Wenkert, Deborah
    Thompson, Elizabeth H. Z.
    Yang, Jun
    Kricorian, Greg
    Koo, John
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 69 (03) : 385 - 392
12345